Publications

Published Works

Implications of the one-year postponement of the application of the Medical Devices Regulation (MDR) LexisNexis

Life Sciences analysis: Regulation (EU) 2020/561 amends Regulation (EU) 2017/745, the Medical Devices Regulation (MDR) by postponing its application to 26 May 2021. Elisabethann Wright and...

Hogan Lovells Publications

Proposed measures in Germany for safeguarding supply of critical goods in the combat against COVID-19

In the wake of combating the COVID-19 pandemic, the German federal government is proposing to enable further measures on a federal level. The proposal includes important measures concerning ...

Hogan Lovells Publications

Highlights from the DigiHealth Leaders Conference: interoperability, reimbursement, patient centricity, and forging effective partnerships

Digital health offers huge potential for improving care and alleviating the increasing burden on our over-stretched healthcare systems. However, its uptake remains slow and varies...

Hogan Lovells Publications

DHSC Update on Medicines and Medical Devices Contingency Planning

Following the recent agreement to delay Brexit until 31 January 2020, the UK Department of Health and Social Care (DHSC) has written to suppliers of UK medicines and medical devices to...

Hogan Lovells Publications

A bit more Sunshine: CMS proposes collecting additional information on manufacturer payments under the Open Payments program Health Alert

Device and drug manufacturers got a small surprise in the annual Physician Fee Schedule proposed rule (at 40,713-16) issued late in July by the Centers for Medicare & Medicaid Services...

News

Influencer Promo Guide: Best Practices for Drug and Device Firms

In our “Influencer promo guide: Best practices for drug and device firms”, we offered a list of best practices for medical device and pharmaceutical companies interested in...

Hogan Lovells Publications

An intelligent approach for regulating medical device AI Medical Device Alert

Hogan Lovells has been at the forefront of advising our clients on the clearance or approval of an increasing number of software as a medical device (SaMD) products and other medical...

Loading data